FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

16683002: Progesterone (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
28249012 Progesterone en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
477894010 PRG - Progesterone en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
743753010 Progesterone (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
835871000172110 progestérone fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
55641000195113 progesterone it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
70691000195113 Progesteron de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Progesterone Is a Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Progesterone derivative false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Pregnane (substance) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Steroid hormone true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progestational hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Ovarian hormone false Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Has disposition Progesterone receptor agonist (disposition) true Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone Is a Substance with progesterone receptor agonist mechanism of action (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Megestrol Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Dydrogesterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethisterone (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Etynodiol diacetate (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestrel Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Noretynodrel Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogesterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Flurogestone acetate Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestimate Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Delmadinone acetate Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Cortodoxone (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
20-hydroxyprogesterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
17-hydroxyprogesterone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone/estradiol ratio measurement Has measured component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone adverse reaction (disorder) Causative agent (attribute) True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone measurement Has measured component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Serum progesterone measurement Has measured component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Radiobioassay - progesterone Component True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone/estradiol ratio measurement Component True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Progesterone measurement Component True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Serum progesterone measurement Component False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 2
Allergy to progesterone Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 100mg/2mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 40 mg/g vaginal gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 80 mg/g vaginal gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 200mg pessary (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 400mg pessary The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 50mg/1mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone-containing product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Rectal/vaginal progesterone The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely progesterone 100 milligram/1 each conventional release oral capsule (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 200 mg oral capsule The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 100mg (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 50mg/mL oil The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 90mg gel The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 50mg/mL injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norelgestromin (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Gestodene Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Gestonorone Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing progesterone (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Estradiol 2 mg and norethisterone acetate 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely estradiol valerate 2 milligram and norethisterone 700 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estradiol+norethisterone acetate 1mg/0.5mg tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol+desogestrel 20micrograms/150micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Desogestrel 150 microgram and ethinylestradiol 30 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30 microgram and levonorgestrel 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol+levonorgestrel 30micrograms/250micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 50 microgram and levonorgestrel 250 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and norethisterone 500 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol+norethisterone 35micrograms/1mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 20 microgram and norethisterone acetate 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30 microgram and norethisterone acetate 1.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol+gestodene 30micrograms/75micrograms tablet (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol+gestodene+placebo 30micrograms/75micrograms tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 20 microgram and gestodene 75 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35 microgram and norgestimate 250 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 20mcg+progestogen (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 30mcg+progestogen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 35mcg+progestogen The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethinylestradiol 50mcg+progestogen (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Estrogen-progestin preparation (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Combined oestogen+progestogen preparations The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Menstrual disorder comb.preps The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone - only contraceptives The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Levonorgestrel 125microgram / Ethinylestradiol 30microgram tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Levonorgestrel 50microgram / Ethinylestradiol 30microgram tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Conjugated estrogen 625 microgram and norgestrel 150 microgram oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Levonorgestrel 75microgram / Ethinylestradiol 40microgram tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Drospirenone (substance) Is a False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 50mg/mL injection solution 10mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Progesterone 20mg topical cream The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Ethynodiol diacetate preparation The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norgestimate-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing desogestrel (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Accidental combined estrogen and progesterone poisoning Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 2
Intentional combined estrogen and progesterone poisoning Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Combined estrogen and progesterone poisoning of undetermined intent Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 2
Estrogen and progestogen preparation adverse reaction Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept) 1
Estrogen and progestogen preparation allergy Causative agent (attribute) False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing allylestrenol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Dydrogesterone 10 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Hydroxyprogesterone hexanoate 250mg/1mL oily injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely medroxyprogesterone acetate 10 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 2.5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely medroxyprogesterone acetate 5 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone 5 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely norethisterone 1 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Lynestrenol-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Mestranol 50 microgram and norethisterone 1 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely etynodiol diacetate 500 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
acétate de médroxyprogestérone 150 mg/mL, seringue préremplie de 1 mL de suspension injectable The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Product containing precisely norethisterone 350 microgram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Norethisterone enanthate 200mg/1mL oily injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Etonogestrel-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Etonogestrel 68mg subdermal implant (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Gestronol hexanoate 200mg/2mL oily injection (substance) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 250 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)
Medroxyprogesterone acetate 500 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Progesterone Inferred relationship Existential restriction modifier (core metadata concept)

Page 1 of 3 Next End


This concept is not in any reference sets

Back to Start